These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33752389)

  • 21. Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: a retrospective cohort study in South Korea.
    Han KT; Kim S
    BMC Cancer; 2022 Feb; 22(1):156. PubMed ID: 35135497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "If it ain't broke, don't fix it": a commentary on the positive-negative results of the ACCORD Lipid study.
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2010 Jun; 9():24. PubMed ID: 20550659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment for dyslipidemias in patients with arterial hypertension].
    Chazova IE; Kukharchuk VV; Ratova LG; Kaminnaia VI
    Ter Arkh; 2007; 79(4):53-7. PubMed ID: 17564020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-lowering therapy: who can benefit?
    Lewis SJ
    Vasc Health Risk Manag; 2011; 7():525-34. PubMed ID: 21915170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-pill combinations (SPCs) and treatment of arterial hypertension in Poland. Expert consensus statement of the Polish Society of Hypertension and Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy.
    Tykarski A; Widecka K; Narkiewicz K; Wożakowska-Kapłon B; Gaciong Z; Grajek S; Grodzicki T; Januszewicz A; Wolf J; Prejbisz A; Kostka-Jeziorny K; Filipiak KJ
    Kardiol Pol; 2017; 75(12):1357-1367. PubMed ID: 29251761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).
    Erdine S; Ro YM; Tse HF; Howes LG; Aguilar-Salinas CA; Chaves H; Guindy R; Chopra P; Moller RA; Schou IM;
    J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease].
    Pérez A; González Blanco C; Hernández-Presa MÁ; Chaves J
    Endocrinol Nutr; 2011; 58(6):283-90. PubMed ID: 21641286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The new dyslipidemia guidelines: what is the debate?
    Anderson TJ; Mancini GB; Genest J; Grégoire J; Lonn EM; Hegele RA
    Can J Cardiol; 2015 May; 31(5):605-12. PubMed ID: 25816728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes Update: Prevention and Management of Diabetes Complications.
    Choby B
    FP Essent; 2017 May; 456():36-40. PubMed ID: 28530383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [C-reactive protein changes with antihypertensive and statin treatment].
    Rodilla E; Gómez-Belda A; Costa JA; Aragó M; Miralles A; González C; Pascual JM
    Med Clin (Barc); 2005 Oct; 125(15):561-4. PubMed ID: 16277947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Only a minority of patients referred for elective coronary artery bypass surgery have risk factors diagnosed and treated according to established guidelines.
    Anderson RE; Brismar K; Ivert T
    Diab Vasc Dis Res; 2007 Jun; 4(2):112-6. PubMed ID: 17654444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of fix dose combination (atorvastatin and amlodipine) in treatment of uncontrolled hypertension and dyslipidemia.
    Bashir S; Sherwani MU; Shabbir I; Batool A
    J Ayub Med Coll Abbottabad; 2011; 23(3):97-100. PubMed ID: 23272446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
    Mazzaglia G; Ambrosioni E; Alacqua M; Filippi A; Sessa E; Immordino V; Borghi C; Brignoli O; Caputi AP; Cricelli C; Mantovani LG
    Circulation; 2009 Oct; 120(16):1598-605. PubMed ID: 19805653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amlodipine/Atorvastatin: a review of its use in the treatment of hypertension and dyslipidaemia and the prevention of cardiovascular disease.
    Curran MP
    Drugs; 2010; 70(2):191-213. PubMed ID: 20108992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age- and gender-specific awareness, treatment, and control of cardiovascular risk factors and subclinical vascular lesions in a founder population: the SardiNIA Study.
    Scuteri A; Najjar SS; Orru' M; Albai G; Strait J; Tarasov KV; Piras MG; Cao A; Schlessinger D; Uda M; Lakatta EG
    Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):532-41. PubMed ID: 19321325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic therapy for cardiovascular risk reduction in patients with the metabolic syndrome.
    Gouni-Berthold I; Berthold HK
    Curr Pharm Des; 2014; 20(31):5025-38. PubMed ID: 24320031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.
    Cardiovasc J Afr; 2009; 20(1):73-4. PubMed ID: 19287821
    [No Abstract]   [Full Text] [Related]  

  • 39. Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction.
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2012 Oct; 11():125. PubMed ID: 23057687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between Prescription and Control Status of Dyslipidemia and Hypertension among Japanese Patients with Diabetes.
    Sakamoto M; Edo N; Takahashi S; Okamura E; Uno K; Morita K; Ishikawa T; Asahi K; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Fujimoto S; Narita I; Konta T; Kondo M; Kimura K; Ohashi Y; Watanabe T; Tsukamoto K
    J Atheroscler Thromb; 2019 Sep; 26(9):805-820. PubMed ID: 30726791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.